Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick

Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick

by Team Small News | Jan 21, 2026 | Dr Reddy's

KPI Green Energy Ltd. has reported impressive financial results for the third quarter, with a 39.4% year-over-year increase in net profit to ₹118 crore. The company’s revenue also saw a significant rise of 44.6% to ₹663 crore during the quarter. Additionally,...
Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick

Indian Pharma Q3 Preview: Strong Domestic Formulations Segment to Offset US Pricing Challenges – scanx.trade

by Team Small News | Jan 16, 2026 | Dr Reddy's

The Indian pharmaceutical industry is expected to experience a mixed bag in the third quarter of the year, with domestic formulations likely to counterbalance the pressure from pricing in the US market. The sector’s growth is anticipated to be driven by a strong...
Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick

Dr Reddy’s introduces generic version of antihistamine eye drops to the US market

by Team Small News | Jan 15, 2026 | Dr Reddy's

Dr. Reddy’s Laboratories has launched an over-the-counter (OTC) eye drop solution, Olopatadine Hydrochloride Ophthalmic Solution, in the US market. The solution is a generic equivalent of Extra Strength Pataday Once-Daily Relief, which is used to provide...
Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick

Dr. Reddy’s Laboratories has been issued a pre-approval inspection letter from the USFDA for its biologics facility located in Hyderabad.

by Team Small News | Jan 13, 2026 | Dr Reddy's

Dr. Reddy’s Laboratories has received a Pre-Approval Inspection (PAI) letter from the US Food and Drug Administration (USFDA) for its biologics facility located in Hyderabad, India. This letter indicates that the USFDA has completed its inspection of the...
Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick

Dr. Reddy’s introduces Hevaxin, India’s inaugural Hepatitis E vaccine approved by the DCGI, specifically designed for adult use.

by Team Small News | Jan 7, 2026 | Dr Reddy's

Dr. Reddy’s Laboratories has launched Hevaxin, a novel recombinant vaccine for the prevention of Hepatitis E virus (HEV) infection in India. This vaccine is the only one approved by the Drug Controller General of India (DCGI) for active immunization against HEV...
Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick

Biotech Healthcare Group names Pankaj Phatak as its new Vice President of Human Resources, as reported by ETHRWorld.

by Team Small News | Jan 3, 2026 | Dr Reddy's

Pankaj Phatak has been appointed as the Vice President of Human Resources at Biotech Healthcare Group. In this role, he will be responsible for driving the HR function globally. Phatak expressed his excitement about the new opportunity, stating that he looks forward...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress